Exploring the Pharmacological Potential of Clitoria Ternatea: In vivo Assessment of its CNS Activity as a Medicinal Herb

Main Article Content

Gejalakshmi.S
N. Harikrishnan

Keywords

Assessment, Pharmacological potency, Clitoria ternatea, Medicinal herb, In vivo, CNS activity, Evaluation, Active compounds, Isolation, Identification, In vitro testing, Animal models, Neurotransmitter systems, Signaling pathways

Abstract

Clitoria ternatea, also known as butterfly pea, is a medicinal herb that has been traditionally used in many parts of the world for various therapeutic purposes. Recent studies have suggested that Clitoria ternatea has potential pharmacological activity in the central nervous system (CNS) and may be useful in treating various neurological disorders.Assessing the pharmacological potency of Clitoria ternatea for in vivo CNS activity evaluation would involve several steps, including the isolation and identification of the active compounds in the herb, in vitro testing of these compounds to determine their potency and efficacy, and in vivo testing in animal models to assess their CNS activity.One approach to identifying the active compounds in Clitoria ternatea would be to use various extraction methods, such as maceration, Soxhlet extraction, and supercritical fluid extraction, to isolate different fractions of the herb. These fractions could then be tested using chromatographic techniques, such as high-performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry (GC-MS), to identify the chemical constituents present in each fraction.Once the active compounds have been identified, in vitro testing could be performed to determine their pharmacological potency and efficacy. This could involve testing the compounds in various assays, such as cell-based assays, receptor binding assays, and enzyme assays, to determine their effects on different neurotransmitter systems and signaling pathways in the CNS.Finally, in vivo testing in animal models would be necessary to assess the CNS activity of Clitoria ternatea. Animal models, such as mice and rats, could be used to evaluate the effects of the herb on various CNS functions, such as cognition, memory, and behaviour. These tests could include the Morris water maze test, the passive avoidance test, and the elevated plus maze test, among others.Overall, the assessment of pharmacological potency of Clitoria ternatea as a medicinal herb for in vivo CNS activity evaluation would require a multidisciplinary approach that includes the isolation and identification of active compounds, in vitro testing of these compounds, and in vivo testing in animal models. Such studies could help to establish the potential therapeutic applications of Clitoria ternatea in treating various CNS disorders.

Abstract 163 | pdf Downloads 186

References

1. Kumar, M., Kumar, S., Gupta, Y.K. Effect of Clitoria ternatea Linn. on learning and memory paradigms in mice. Indian Journal of Physiology and Pharmacology,2007; 51(2): 93-100.
2. Singh, B., Singh, V. P., Pandey, V. B., & Singh, N. Anxiolytic activity of standardized extract of Clitoria ternatea Linn. Pharmacognosy Research,2010; 2(1): 20-25.
3. Dhanasekaran, M., Tharakan, B., Holcomb, L. A., & Hitt, A. R. Anti-inflammatory activity of Clitoria ternatea in Sprague-Dawley rats. Inflammopharmacology, 2007;15(5):240-245.
4. Sumathi, T., Shobana, S., Kumudhavalli, M. V., & Nandhakumar, J. Evaluation of CNS depressant activity of Clitoria ternatea Linn. International Journal of PharmTech Research, 2011;3(2): 893-899
5. Pawar, R. S., Toppo, F. A., Mandloi, S., & Jain, A. P. Clitoria ternatea Linn. (Butterfly pea): A review on its phytochemical and therapeutic potential. Natural Product Research, 2014;28(23): 2138-2159.
6. Kumar, A. et al. Clitoria ternatea (L.): Old and new aspects. Pharmacognosy Reviews, 2013;7(14):36-41
7. Singh, P., & Chaturvedi, S. Anxiolytic effect of standardized extract of Clitoria ternatea Linn. in mice. Indian Journal of Experimental Biology, 2011;49(12): 939-945.
8. Verma, P. R., & Madhavan, V. Neuroprotective effect of Clitoria ternatea L. against global cerebral ischemia-reperfusion injury induced in rats. Journal of Traditional and Complementary Medicine,2016; 6(3): 251-256.
9. Taranalli, A. D., Cheeramkuzhy, T. C., & Manjunath, S. (2013). Evaluation of anxiolytic activity of standardized Clitoria ternatea root extract in experimental animals. Avicenna Journal of Phytomedicine, 2013;3(3): 249-256.
10. Kasture, S. B., Kasture, V. S., Chopde, C. T., & Deshmukh, V. K. Anxiolytic and anticonvulsive activity of saponin isolated from the leaves of Clitoria ternatea Linn. Indian Journal of Pharmacology, 2000;32(4): 284-288.
11. Sharma, A. K., Kumar, S., & Tripathi, P. Clitoria ternatea (Linn.)- A review on its ethnobotany, pharmacology and phytochemistry. International Journal of Pharmaceutical Sciences and Research,2011; 2(5): 1115-1120.
12. Chauhan, P., Sharma, D., & Singh, R. Neuroprotective efficacy of Clitoria ternatea in experimental autoimmune encephalomyelitis. Pharmaceutical biology,2019; 57(1): 43-50.
13. Lekha, G. L., Chandra, V., Sharmila, J., & Karthikeyan, R.Neuroprotective effect of Clitoria ternatea against cuprizone induced demyelination. Asian Pacific Journal of Tropical Biomedicine, 2017;7(10): 924-930.
14. Sree Lekshmi. R. S, P. Shanmugasundaram. Neuroprotective Properties of Statins. Research J. Pharm. and Tech2018;11(8): 3581-3584. doi: 10.5958/0974-360X.2018.00659.
15. C. U. Pavithra, K. Swetha, S. Ivo Romauld, P. Brindhadevi. A Review on Multiple Sclerosis and its Regimens. Research J. Pharm. and Tech. 2020;13(8):3977-3982. doi: 10.5958/0974-360X.2020.00703.9
16. Antony Justin, Meghana Basavaraj, Deepthi Murugan, Gaddam Narasimha Rao, Jeyaram Bharathi J. Role of A1 Adenosinergic System in Multiple Sclerosis and Possible Therapeutic Strategy. Research Journal of Pharmacy and Technology. 2022;15(7):3025-8. doi: 10.52711/0974-360X.2022.00505(2022)
17. Antony Justin, Deepthi Murugan, Meghana Basavaraj, Ashwini Prem Kumar. Are 5HT7 Receptors Possible Target for Multiple SclerosisResearch Journal of Pharmacy and Technology2023; 16(3):1514-0. doi: 10.52711/0974-360X.2023.00248(2023)